Francis Crick Institute

#Aging Cell #Cellular stress #Francis Crick Institute #Imperial College London #Medical research #Medical Research Council #MRC Laboratory of Medical Sciences #Queen Mary University of London #University of Cologne #University of Lyon

Drug extends animal life by activating ‘energy saver’ mode 

Scientists have successfully used a drug to prolong the lifespan of several species of animals, in some cases by more than 25%.  The study, published in Aging Cell, found strong evidence that triggering a protein, governing energy levels, may help organisms live significantly longer. … Read More

#News

Immunotherapy
#Cancer immunotherapy #CRISPR #Francis Crick Institute #Immune response

Immune cell behaviour challenges traditional classification 

Researchers at the Francis Crick Institute, King’s College London and Complutense University of Madrid have shown that γδ T cells use adaptive immune receptors to drive rapid, innate-like responses to tissue stress, inflammation and cancer.  Researchers have long divided the immune system into two broad arms: innate… Read More

#News

Neural networks
#AI / data analytics / healthtech / informatics #Cancer Research Horizons #Drug discovery #Francis Crick Institute #Medicines Discovery Catapult (MDC)

National programme to support data-driven health start-ups 

Applications have opened for a national accelerator programme supporting data-driven health innovation.  KQ Labs, led by the Francis Crick Institute and Medicines Discovery Catapult (MDC), is an annual five-month programme for early-stage companies building science-backed, scalable solutions in AI-driven drug discovery, digital health, and precision medicine. … Read More

#News

#Cancer research #Clinical trial #Drug discovery #Francis Crick Institute #Funding #Genetic profiling #GLP-1 #Lung cancer #MHRA #National Institute for Health and Care Research #Obesity #Oncology #Rare disease #Regulatory #The Royal Marsden NHS Foundation Trust #University College London #Weight loss

DDW Highlights: 16 June 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, new research showed anti-IL-1β drugs could prevent lung cancer. Elsewhere, the… Read More

#Podcasts

#Francis Crick Institute #Lung cancer #Oncology #University College London

New research suggests anti-IL-1β drugs could prevent lung cancer

Researchers at the Francis Crick Institute and University College London (UCL) have identified a 14-protein signature in the blood that could identify who would benefit from cancer prevention drugs.  The signature enabled the team, funded by Cancer Research UK and the European Research Council (ERC), to predict… Read More

#Cancer Research #Editor's Choice #News

#AstraZeneca #Drug discovery #Europe #European Federation of Pharmaceutical Industries and Associations #FDA #Francis Crick Institute #Hypertension #Lung cancer #Mental health #Tropical disease #University of Dundee #Wellcome Trust

DDW Highlights: 26 May 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, a report showed patients in Europe face barriers to medicine access. Elsewhere,… Read More

#Podcasts

#AC Immune #Alzheimer's #Cancer Grand Challenges #Cancer immunotherapy #Childhood cancer #Clinical trial #Eli Lilly #FDA #Francis Crick Institute #Genetics #GLP-1 #Neurodevelopmental disorders

DDW Highlights: 14 April 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, researchers discovered how genetic mutations cause a previously unknown recessive condition. Elsewhere, Eli… Read More

#Podcasts

#AC Immune #Alzheimer's #Cancer Grand Challenges #Cancer immunotherapy #Childhood cancer #Clinical trial #Eli Lilly #FDA #Francis Crick Institute #Genetics #GLP-1 #Neurodevelopmental disorders

This week in Drug Discovery (6 – 10 April) 

News round-up for 6 – 10 April by Bruno Quinney, Content Team at DDW.  This week, researchers have discovered how genetic mutations cause a previously unknown recessive condition. Elsewhere, Lilly has made the headlines for both an approved drug and a drug collaboration.  The top stories: … Read More

#News

Research in genetics laboratory
#Francis Crick Institute #Genetics #Neurodevelopmental disorders #University of Oxford

Research uncovers previously unknown recessive condition 

Researchers have discovered how genetic mutations can cause neuro-developmental disorders, including a previously unknown recessive condition.  Scientists at the University of Oxford and the Francis Crick Institute, in collaboration with international partners, have made advances in understanding how mutations in a single non-coding gene contribute to neurodevelopmental… Read More

#News

#AlveoliX #Francis Crick Institute #Lung disease #New approach methodologies (NAMs) #Organ-on-a-chip

First ‘lung-on-chip’ developed using genetically identical cells

Researchers at the Francis Crick Institute and AlveoliX have developed the first human ‘lung-on-chip’ model using stem cells taken from only one person.  These chips simulate breathing motions and lung disease in an individual, holding promise for testing treatments for infections like tuberculosis (TB) and delivering personalised… Read More

#Editor's Choice #News

Patient on ventilator
#Covid-19 #Covid-19 treatment #Drug repurposing #Francis Crick Institute #Pneumonia #University College London

Repurposed drug treats severe Covid-19 pneumonia

A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe Covid-19 pneumonia in a recent clinical trial. The drug, dornase alfa, could be used to treat other respiratory infections, according to the data from researchers at UCL, UCLH and the Francis Crick… Read More

#News #Trending News

#Francis Crick Institute #Genetics / genomics #Kidney cancer #Oncology

Gene mapping predicts cancer variants with 100% accuracy

Researchers at the Francis Crick Institute have mapped all the possible outcomes of changes to a tumour-suppressing gene called VHL. The VHL map could help clinicians work out which patients are at risk of developing kidney cancer or might respond to certain drugs. It… Read More

#Cancer Research #News

#Antibody drug conjugate (ADC) #Financing #Francis Crick Institute #Imperial College London #Myricx Bio #Start-ups

Myricx Bio announces £90m ($114m) Series A financing

UK biotech Myricx Bio has raised £90 ($114) million Series A financing to support the development of its N-Myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) therapeutics. The round was co-led by new investors Novo Holdings and Abingworth, with additional support from British Patient Capital, Cancer Research Horizons and Eli Lilly, plus… Read More

#Business & Investment #News #Trending News

Melanoma or skin cancer
#Dermatology #Francis Crick Institute #Gene therapy #Great Ormond Street Hospital #Melanoma #RNA

Silencing RNA causes moles to self-destruct in rare condition

UK researchers have designed a new genetic therapy that could alleviate debilitating giant moles in a rare skin condition. The treatment could be used to reverse moles, and therefore prevent cancer. It could also potentially reverse other types of at-risk moles as an alternative to surgery. Read More

#News

Francis Crick Institute
#Collaboration #Drug discovery #Francis Crick Institute #Research and development

UK academic-SME collaborations bring new tech to drug discovery

The Francis Crick Institute in the UK has announced the inception of six partnerships with small and medium-sized enterprises (SMEs), focussed on the application of novel technologies to discovery projects led by Crick researchers. The collaborations are supported by a Business Engagement Fund award from the… Read More

#News

#Amyotrophic lateral sclerosis (ALS) #Biotechnology #Broken String Biosciences #DNA #Francis Crick Institute #Genomics

UK industry collaboration to advance ALS research 

Broken String Biosciences has entered a research collaboration with the Francis Crick Institute, focused on leveraging technology to investigate the impact of genomic instability in the development of amyotrophic lateral sclerosis (ALS).  The aim to achieve this is through the development of novel applications for Broken String’s… Read More

#News